Patents Assigned to NxStage Medical, Inc.
  • Publication number: 20170296734
    Abstract: A system associated with a medical treatment device for detecting a condition of a patient includes an input device including at least a camera or a microphone. The system also includes a medical treatment device with a controller/classifier and at least one of flow controller, a pump, and/or an alarm output. The controller/classifier has at least a video-image processor or an audio processor configured to recognize a face and a body or to recognize changes in skin color, facial expression, or body position. The controller/classifier may also recognize speech and classify predefined normal and irregular sound patterns, and output state data corresponding thereto. The controller/classifier is connected to apply the state data to the at least one flow controller, pump, and/or alarm output. The controller/classifier is further adapted to control the at least one flow controller, pump, and/or alarm output responsively to the state data.
    Type: Application
    Filed: July 5, 2017
    Publication date: October 19, 2017
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Publication number: 20170290970
    Abstract: A medicament preparation system, according to an embodiment, includes a water purification module and a medicament proportioning module. The system is configured to allow convenient and safe use in a home environment or a critical care environment as well as others affording safety, reliability, and a compact form factor.
    Type: Application
    Filed: September 25, 2015
    Publication date: October 12, 2017
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Goetz FRIEDERICHS, William WEIGEL, Dennis M. TREU, Jeffrey H. BURBANK, James M. BRUGGER, Keith J. WHEELER, Scott W. NEWELL
  • Publication number: 20170266360
    Abstract: A fluid preparation system has a sealed sterilized fluid circuit with a sealed sterilized container with a conductivity sensor in communication with an interior of said container. Further, at least one sealed connector is adapted for adding fluid to said container, and at least one sealed connector is adapted for removing fluid from said container. The conductivity sensor is contained in a test line in communication with said interior and is adapted to be connected to a source of suction thereby to draw a sample of contents of said container. Furthermore, the test line may have a check valve to prevent ingress of contaminants into said container, and the sealed connector is adapted for adding fluid to said container and may have an inline sterile filter. Furthermore, the system may have a controller that controls pumping actuators.
    Type: Application
    Filed: June 6, 2017
    Publication date: September 21, 2017
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, Dennis M. TREU, Goetz FRIEDERICHS, Brian C. GREEN, Christopher S. MCDOWELL, James M. BRUGGER
  • Publication number: 20170232175
    Abstract: A peritoneal dialysis device includes a disposable tubing set that includes a fill line with a patient access connector at one end and a dialysis fluid receiving end opposite the patient access connector end. The device also includes a fill-side pressure measuring sensor attached at the fill end and forming a disposable component of the tubing set and a patient-side pressure measuring sensor located at the fluid receiving end. The patient-side and fill-side pressure measuring sensors are adapted for measuring pressure in the fill line at the respective ends thereof. The device also includes a controller configured to regulate a rate of flow in the fill line responsively to a signal from the at least the patient-side pressure measuring sensor.
    Type: Application
    Filed: March 31, 2017
    Publication date: August 17, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Patent number: 9724459
    Abstract: Features for protecting against leaks in a fluid circuit are disclosed. In a first embodiment, a fluid circuit is housed by another fluid circuit that is configured to capture and convey leaks to leak detector. In a second embodiment, a first indicator of a leak is used to trigger confirmation by blood flow reversal and air detection in the blood circuit.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: August 8, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, Dennis M. Treu, James M. Brugger, Daniel Joseph Rubery, Jr.
  • Patent number: 9717840
    Abstract: One of the most significant safety concerns in the automation of extracorporeal blood treatments such as dialysis is the risk of blood leakage. Extracorporeal blood treatment systems draw blood at such a high rate that a loss of integrity in the blood circuit can be serious. There are a number of mechanisms for detecting and preventing leaks, but none is perfect. This tends to limit the use of such equipment in unsupervised settings, such as the home will be limited. Some leak detection schemes can be made sensitive enough to detect the barest of leaks, but when this is done, they result in too many false positives. The invention combines information from multiple inputs to enhance sensitivity in leak detection and reduce the problem of false positives.
    Type: Grant
    Filed: January 16, 2014
    Date of Patent: August 1, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Publication number: 20170203027
    Abstract: A method of performing a peritoneal dialysis treatment includes connecting a disposable unit to a source of water, the disposable unit including at least a first container holding a sterile concentrate containing an osmotic agent, a second container holding a sterile concentrate containing electrolytes, an empty sterile mixing container, and a tubing set with a pre-attached peritoneal fill/drain line. The method further includes receiving a prescription command by a controller, indicating at least the fill volume and desired final concentration of the osmotic agent to be used for a current fill cycle under said treatment, and using the controller, pumping a quantity of the concentrated osmotic agent that is at least sufficient to achieve the desired final concentration into the mixing container. The contents of the mixing container are mixed, further diluted or concentrated, and then flowed to a patient.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Publication number: 20170203025
    Abstract: A disposable fluid circuit used in a medical device that performs peritoneal dialysis includes a peritoneal dialysis tubing set that has a connection tube with a connector for a peritoneal catheter at a distal end and a connector configured to connect to a peritoneal cycler at a proximal end. The circuit also includes a pressure pod at the distal end, the pressure pod being of the type that has a flow chamber for carrying a liquid and an air chamber separated from the flow chamber by a diaphragm and an air port in fluid communication with the air chamber. The flow chamber is connected in-line with a lumen of the connection tube and a length of tubing runs from the air-port along the length of the connection tube with a connector at the proximal end configured to connect to a pressure transducer.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Publication number: 20170203024
    Abstract: A method of performing a peritoneal dialysis treatment includes connecting a disposable unit to a source of water. The disposable unit includes at least a first container holding a sterile concentrate containing an osmotic agent, a second container holding a sterile concentrate containing electrolytes, an empty sterile mixing container, and a tubing set with a pre-attached peritoneal fill/drain line. The method also includes receiving a prescription command by a controller, indicating at least the fill volume and desired final concentration of the osmotic agent to be used for a current fill cycle under said treatment, and pumping a quantity of the concentrated osmotic agent that is at least sufficient to achieve the desired final concentration into the mixing container. The contest of the mixing container are mixed, further diluted or concentrated, and then flowed to a patient.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Publication number: 20170203026
    Abstract: A method of performing a dialysis treatment includes using a pump and a dialysate supply line to transport peritoneal dialysis fluid, the supply line having a proximal end into which peritoneal dialysis fluid is supplied and from which spend dialysate is withdrawn, and a distal end which is connected to a patient's peritoneal access. The method further includes generating proximal and distal pressure signals using pressure detectors located at both the proximal and distal ends, respectively, of said supply line. During a drain cycle in which spent dialysate is pumped from the patient, the method includes, responsively to the proximal and distal pressure signals, detecting a characteristic of a pressure difference between the distal and proximal ends whose magnitude is determined by a predicted change in dialysate properties, and responsively to the characteristic, generating a signal indicating the change in dialysate properties.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Publication number: 20170203022
    Abstract: A system that fills multiple containers includes a filter with an inlet port and multiple outlet ports. The outlet ports are pre-attached to containers by respective filling lines of each container. Each container has an interior and each of the respective filling lines is connected to a respective container interior. All of the respective filling lines are sealed to the outlet ports and the containers such that the container interiors are isolated from an external environment except the inlet port, via the filter, forming a combined interior volume which is sterile. The system can produce batches of multiple sterile containers with sterile medicament in the containers.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Applicant: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER
  • Patent number: 9700663
    Abstract: Systems, methods, and devices for preparation of water for various uses including blood treatment are described. In embodiments, fluid is passed either by pump or passively by gravity feed, through various filtration elements from a fluid source to a treatment fluid container. The latter forms a batch that may be used during treatment. Methods and systems for creating multiple-treatment batches are described. Advantages of creating a multitreatment batch include the fact that the burden of treatment preparation can be reduced and the timing of the preparation of the batch can be independent of the treatment time. As described, there are various trade-offs and concerns with this approach which are addressed by the inventive embodiments.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: July 11, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, Dennis M. Treu, Götz Friederichs, Brian C. Green, Christopher S. McDowell, James M. Brugger
  • Publication number: 20170189626
    Abstract: Systems, methods, and devices can detect a dangerous or adverse condition or anticipated condition that indicates an undesirable amount of electric current in a patient-connected tube providing fluid to a patient. The fluid flow to the patient is stopped responsive to the detection. Stoppage of fluid flow to the patient can reduce or prevent electric current in the fluid from reaching a patient, flowing through the patient to ground, and/or continuing to flow through the patient.
    Type: Application
    Filed: March 22, 2017
    Publication date: July 6, 2017
    Applicant: NXSTAGE MEDICAL, INC.
    Inventor: Yakov KOGAN
  • Publication number: 20170182237
    Abstract: An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals. Other features and embodiments are disclosed.
    Type: Application
    Filed: January 7, 2017
    Publication date: June 29, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
  • Patent number: 9636444
    Abstract: Systems, methods, and devices for preparation of purified water and medicaments for various uses including blood treatment are described. Methods, devices, and systems for creating multiple-treatment batches are described. For example, a medicament fluid circuit can include a container with an interior chamber. The container can have a fluid filling port and a fluid extraction port. Both ports can be connected to the interior chamber. The filling port can have two sterilizing filters, each of which has a membrane. The sterilizing filters can be connected in series the membranes are separated by a distance of at least 0.5 cm. A first of the sterilizing filters can have a sealed inlet. The fluid extraction port can be sealed.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: May 2, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: Jeffrey H. Burbank, James M. Brugger
  • Patent number: 9636454
    Abstract: Systems, methods, and devices can detect a dangerous or adverse condition or anticipated condition that indicates an undesirable amount of electric current in a patient-connected tube providing fluid to a patient. The fluid flow to the patient is stopped responsive to the detection. Stoppage of fluid flow to the patient can reduce or prevent electric current in the fluid from reaching a patient, flowing through the patient to ground, and/or continuing to flow through the patient.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: May 2, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventor: Yakov Kogan
  • Publication number: 20170028119
    Abstract: A pressure measurement system for use in blood circuits comprised of a pressure sensing pod and a force measurement device. The pressure sensing pod can include a flexible, moveable, fluid-impermeable diaphragm and can be formed via either a one-shot or a two-shot molding process. A mechanical engagement member of the force measurement device engages with a mechanical engagement feature of the diaphragm, and the engagement member is operative to move in concert with movement of the engagement feature of the diaphragm based on pressure variations with the pressure sensing pod. The force measurement device generates and outputs to a processor a signal based on detected force associated with movement of the engagement member.
    Type: Application
    Filed: July 26, 2016
    Publication date: February 2, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: James M. Brugger, Dennis M. Treu, Jeffrey H. Burbank, Scott W. Newell, William J. Schnell, Kenneth E. Buckler
  • Patent number: 9551625
    Abstract: A pressure measurement system for use in blood circuits comprised of a pressure sensing pod and a force measurement device. The pressure sensing pod can include a flexible, moveable, fluid-impermeable diaphragm and can be formed via either a one-shot or a two-shot molding process. A mechanical engagement member of the force measurement device engages with a mechanical engagement feature of the diaphragm, and the engagement member is operative to move in concert with movement of the engagement feature of the diaphragm based on pressure variations with the pressure sensing pod. The force measurement device generates and outputs to a processor a signal based on detected force associated with movement of the engagement member.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: January 24, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: James M. Brugger, Dennis M. Treu, Jeffrey H. Burbank, Scott W. Newell, William J. Schnell, Kenneth E. Buckler
  • Publication number: 20170001887
    Abstract: A fluid purification system has cells whose purifying capability can be regenerated. Some of the cells are arranged in series to reach a high level of purification. An automatic valve network is controlled to cycle the cells in a way that levels the loads on each, thereby maximizing the service interval for replacing expired cells, enabling all of the cells to be replaced at the same time after having each contributing approximately equally to the purification load, and operated such that at any one time, at least one cell is regenerated so as to enable continuous up-time.
    Type: Application
    Filed: June 20, 2016
    Publication date: January 5, 2017
    Applicant: NxStage Medical, Inc.
    Inventors: William K. Weigel, Goetz Friederichs, Joseph E. Turk, Jeffrey B. Hover, SR.
  • Patent number: 9533088
    Abstract: A flow reversing device for performing blood treatment can include a flow reversing actuator. The flow reversing actuator can receive and engage a disposable tubing set with multiple branches that form forward and reverse blood flow paths respectively when blood the flow reversing actuator is selectively changed between forward and reverse configurations. The shape of the tubing can be such that during forward operation, dead regions of non-flowing blood are defined. The flow reversing actuator can have a controller configured to operate generally in forward mode. At first times, the controller can cause the flow reversing actuator to clear the dead regions. At second times, the controller can cause the flow reversing actuator to test for leaks by reversing the flow of blood for a period of time sufficient to cause air to be drawn into the tubing set and conveyed to an air sensor.
    Type: Grant
    Filed: June 27, 2013
    Date of Patent: January 3, 2017
    Assignee: NXSTAGE MEDICAL, INC.
    Inventors: James M. Brugger, Christopher McDowell